Meeting EU Drinking Water Standards: The Critical Role of Sample Prep in Trace Contaminant Analysis

Although modern agriculture needs to be based on accurate real-time data on soil, plant, and environmental conditions, affordable, sufficiently sensitive, and robust monitoring devices for this purpose are currently missing. According to scientists, low-cost sensors based on new smart materials and printing technologies offer a suitable solution. The results of multidisciplinary research thus far and proposals for the development of these devices have been presented by researchers from Czechia, Great Britain, Spain, and the USA in a review article in the prestigious journal <a target="_blank" rel="noopener noreferrer" href="https://www.nature.com/articles/s41467-026-68778-6#Abs1">Nature Communications</a>.“Sensor technologies for monitoring plant health are still in their infancy. Only simple sensors capable of monitoring basic parameters such as pH, soil moisture, or temperature are commonly available on the market. However, if farmers are to face current challenges, including climate change, and ensure sufficient food for humanity, they need much more effective tools that will enable them to monitor, for example, various pathogens, including bacteria and fungi. In our opinion, a suitable solution is a combination of new smart materials and printing for the production of inexpensive, durable, and scalable materials,” said the article’s first author, David Panáček from CATRIN, who worked on the study during his internship at Imperial College London.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CATRIN_Soucasne_senzory_nestaci_Vedci_navrhuji_novou_cestu_ke_sledovani_zdravi_rostlin_b4014952a3.jpg" alt="CATRIN: David Panáček" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CATRIN_Soucasne_senzory_nestaci_Vedci_navrhuji_novou_cestu_ke_sledovani_zdravi_rostlin_b4014952a3.jpg 208w," sizes="100vw" width="1536" height="1152">Sensors for monitoring plant health, for example, lag behind similar devices used in human medicine. According to the authors, advances in materials science, which will enable the development of scalable sensor technologies, play a key role in this potential shift. “Printing techniques, including inkjet printing, screen printing, aerosol printing, 3D printing, and direct laser writing, offer flexible ways to produce flexible sensors, large-area sensors, and sensors integrated directly into plants. The review article summarizes recent advances in printable low-dimensional materials for agricultural sensors, analyzes their physico-chemical properties in relation to sensor performance, and discusses key challenges and future opportunities requiring interdisciplinary integration,” said one of the corresponding authors, Michal Otyepka.The research brought together materials scientists, chemists, biologists, sensing experts, and printing technology specialists. Materials research and the use of graphene-based smart materials were led by scientists from CATRIN at Palacký University and VŠB-Technical University of Ostrava. Plant biologists from CATRIN contributed their knowledge of plant development, their responses to stress conditions, and the monitoring of their properties. Researchers from Imperial College London took care of the electronics, while representatives from<a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/companies/36"> CEITEC – VUT</a> focused on printing technologies. The team also included leading experts in sensing from the Catalan Institute of Nanoscience and Nanotechnology in Barcelona, and Joseph Wang of the University of California San Diego, the “father of sensing and electrochemistry,” also contributed his extensive knowledge.“This is a groundbreaking study on this topic, which has managed to attract some truly big names in their respective fields. Last but not least, the study demonstrates that interdisciplinarity at CATRIN gives rise to completely new and promising research topics, such as plant sensing and its use for studying plant-environment interactions and smart agriculture,” added another corresponding author, Nuria De Diego.

Current sensors are not good enough. Scientists propose a new way to monitor plant health

In this episode of the Concentrating on Chromatography podcast, host David Oliva interviews Ainslie Chen about her cutting-edge research on hemoglobin variant testing using liquid chromatography-high resolution mass spectrometry (LC-HR-MS). Ainslie discusses her novel method for separating and identifying hemoglobin subunits with mass shifts less than 1 Da, overcoming critical limitations in conventional clinical assays.Hear firsthand how her team developed an LC-HR-MS workflow using a C4 reversed-phase column, tackled technical challenges (including why C18 columns fell short), and achieved unprecedented sensitivity for variant detection in both adult and neonatal samples. The conversation touches on the potential of mass spectrometry to revolutionize clinical diagnostics, the importance of reproducibility, barriers to adoption in routine labs, and how teamwork drives scientific innovation.Perfect for analytical chemists, clinical laboratorians, and anyone interested in the future of protein variant analysis, this episode also features Ainslie’s advice for early-career scientists and insights from her first ACS poster presentation.<h4>Key Highlights:</h4><ul><li>Motivation behind improving hemoglobinopathy testing &nbsp;</li><li>Technical advantages of LC-HR-MS over gene sequencing and CE &nbsp;</li><li>The crucial role of the C4 column in resolving challenging samples &nbsp;</li><li>Critical parameters for reproducible LC-HR-MS workflows &nbsp;</li><li>Barriers and outlook for clinical adoption of advanced mass spectrometry &nbsp;</li><li>The value of teamwork and mentorship in scientific research &nbsp;</li><li>Direct insights from recent ACS conference experiences</li></ul><h3>Video transcription</h3>In this interview, Ainslie Chen discusses her research on improving the detection and identification of hemoglobin variants using liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS). The work addresses limitations of conventional hemoglobinopathy testing, which often struggles to resolve very small mass differences between closely related hemoglobin subunits. Because even a single amino-acid substitution can significantly alter hemoglobin structure and function, high analytical resolution is essential for accurate diagnosis of conditions such as anemia and sickle cell disease.Chen explains why her team selected LC-HRMS over established clinical techniques like capillary electrophoresis and gene sequencing. While sequencing offers excellent accuracy, it is time-consuming, costly, and requires extensive sample preparation, making it impractical for routine clinical workflows. Capillary electrophoresis enables subunit separation but lacks the resolving power needed to distinguish variants differing by less than one Dalton. In contrast, high-resolution mass spectrometry provides both structural specificity and sensitivity, enabling confident identification of subtle hemoglobin variants with minimal sample preparation.A key methodological insight from the project was the use of a C4 reversed-phase LC column instead of the more common C18 column. Chen describes how the shorter carbon chain and larger pore size of C4 columns improved protein elution and reduced denaturation, leading to more reproducible separations. Critical parameters for reproducibility included consistent mobile-phase composition (0.1% formic acid in water and acetonitrile), controlled temperature (60 °C for LC, ~320 °C capillary temperature), and stable chromatographic conditions.Beyond hemoglobin analysis, Chen highlights the broader potential of high-resolution mass spectrometry in proteoform analysis and clinical diagnostics, including emerging applications in cancer detection. She acknowledges current barriers to clinical adoption—such as energy demands and instrument infrastructure—but points to advances like miniaturized mass spectrometers as promising steps toward wider use. The interview concludes with advice for young scientists: don’t hesitate to reach out to mentors, embrace collaboration, and view analytical chemistry as a versatile tool that bridges medicine, biology, environmental science, and beyond.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

Unlocking Hemoglobin Variant Detection: LC-HR-MS Breakthrough with Ainslie Chen

Article

Video

Environment

Scientific article

Interview

Science and research

The Czech Advanced Technology and Research Institute (CATRIN) at Palacký University is a cutting-edge scientific hub dedicated to advancing research in the fields of nanotechnology, biotechnology, and biomedicine. At its core, CATRIN boasts outstanding scientific teams, featuring international researchers. We emphasize interdisciplinarity, foster global collaborations, and work to translate our research findings into practical applications.

CATRIN

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Agilent Technologies

US HUPO

Bruker

Phenomenex

Thermo Fisher Scientific

Waters Corporation

<h3>Solving Problems That Matter - a Waters webinar series featuring USP speakers</h3><h4>Episode 8: Lipid nanoparticles</h4><div class="summary-section section">Developing safe, compliant and efficacious lipid nanoparticles (LNP) requires adequate testing of the individual lipid components and impurities. In this webinar Anni Chang from the USP Excipient team will share current and future excipient solution approaches and describe how the USP provides support for stakeholders in discovery and early-stage development. Then Duanduan Han will discuss the benefits of mass detection for critical impurities analysis, and Empower software workflows for compliant and straightforward method migration from development to QC labs. Duanduan will also highlight how multi-angle light scattering (MALS) detection can be used to characterize the LNP.<h5>Key learning objectives</h5><ul><li>Explore current and future USP solutions for lipid nanoparticles (LNP)</li><li>Learn how mass detection and Empower software-based workflows expedite and enhance routine testing of LNP components and impurities</li><li>Discover orthogonal insights enabled by multi-angle light scattering detection (MALS)</li></ul><h5>Who should attend</h5>Scientists involved with lipid nanoparticle analysis<blockquote>Presenter: Anni Chang, Ph.D. (Sr Scientist II, Excipients Unit, US Pharmacopeia)Dr. Anni Chang is currently a Senior Scientist II in the Excipients unit at the United States Pharmacopeia (USP). In her current role, she is responsible for developing, revising, and modernizing USP monographs. One of her focus areas is lipid excipients used in nanomaterial carriers.Dr. Chang has more than 15 years of experience in the biotech/pharmaceutical industry in analytical method development, validation, and transfer. She received her Ph.D. in Chemistry from University of Maryland, College Park, Maryland, USA. Dr. Chang is also active in the American Association of Pharmaceutical Scientists and serves as a Member Engagement Manager in the Lipid Based Drug Delivery community.Presenter: Duanduan Han, Ph.D. (Senior Scientist QA/QC Biologics Solutions group, Waters Corporation)Duanduan is a Senior Scientist in the QA/QC Biologics Solutions group at Waters Corporation headquarters in Milford, MA. She joined Waters in 2021, and she has focused on LC method development in composition analysis, impurity profiling, and raw material screening of lipid nanoparticle components and products. Additionally, she has explored other subjects of pharmaceutical analysis including surfactant, protein, and peptide. Prior to joining Waters, she received her PhD in chemical engineering from Texas A&amp;M University.Presenter: Panelist: Martin Kurnik, Ph.D. (Senior Scientist, Analytical Sciences, Waters | Wyatt Technology​)Martin Kurnik is a senior scientist in the Analytical Sciences team at Waters | Wyatt Technology. He helps customers identify and develop the best solutions for their analytical needs by leveraging his expertise in multi-angle light scattering and dynamic light scattering as well as a wide range of other leading techniques for biomolecular characterization. His postdoctoral research in protein folding and misfolding biophysics focused on understanding and preventing misfolding in bulk solution and on artificial surfaces used in medicine and biotechnology, and he has also developed protein- and aptamer-based electrochemical biosensors for continuous real-time measurements in vitro and in vivo. Martin received his M.Sc. in Chemistry and Ph.D. in Biochemistry from Stockholm University, Sweden.Moderated by: Isabelle Vu Trieu (Pharmaceutical Market Development Manager, Americas, Waters Corporation)Isabelle is a business development professional dedicated to delivering benefits to analytical scientists in the life sciences industry. With over 20 years of experience in providing chromatography and mass spectrometry solutions, Isabelle is particularly interested in helping pharmaceutical scientists achieve the data quality and integrity needed to drive decisions for drug quality, safety and efficacy. Isabelle joined Waters in 2009 and currently manages the development of the pharmaceutical market in the Americas. She holds Masters’ degrees in Chemistry from Columbia University and the University Claude Bernard in Lyon, France as well as a Chemical Engineering degree from Ecole Supérieure de Chimie Physique Electronique in Lyon, France.</blockquote></div>

Waters Corporation: Solving Problems That Matter - a Waters webinar series featuring USP speakers

Lipid nanoparticles

Solving Problems That Matter - a Waters webinar series featuring USP speakers. Episode 8: Complex excipients: Lipid nanoparticles.

Complex excipients: Lipid nanoparticles

<h4>Automating Laboratory Workflows with Andrew+ and OneLab Software: A Virtual Demonstration</h4>
We are excited to invite you to our upcoming webinar series on how to easily bring automation to your lab and transform your current workflows.
<h4>EPISODE 3 - Food and Environmental Workflows</h4>
In this episode, we’re excited to show off Andrew+, an advanced pipetting robot, and OneLab, a workflow design execution software. Both are game-changers in analytical workflows, particularly in fields related to food testing and environmental monitoring, where reliable sample preparation in complex matrices is often crucial
In this episode, we’ll show how Andrew+ and OneLab use automation to streamline everything from drug discovery to quality control.
In this episode, you will:
<ul>
<li>Hear insights directly from one of our esteemed customers in the the food and environmental industry, who kindly agreed to make a short video interview about their experience.</li>
<li>Take a tour of the user-friendly OneLab Software, showing how Andrew+ can be intuitively guided to carry out complex tasks. This reduces manual labor and minimizes errors.</li>
</ul>
Andrew+ and OneLab can automate sample preparation protocols, including:
<ul>
<li>General liquid handling</li>
<li>Serial dilutions</li>
<li>Concentration normalizations</li>
<li>And even more complex workflows involving filtration, sample extraction or magnetic beads.</li>
</ul>
These steps are crucial for ensuring the accuracy and reliability of subsequent analytical procedures.
We’ll also talk about data management capabilities, highlighting how OneLab ensures data integrity and helps meet regulatory standards.
So, come join us for this demonstration!
Not sure to be able to attend live sessions?
Register today and watch the webinars on-demand
<h4>Other episodes rfom the series:</h4>
Transform Your Daily Lab Operations with Automation - Episode 1: Biomolecules workflows
<ul>
<li>Tuesday, June 11, 2024, 11:00 AM CEST</li>
</ul>
Transform Your Daily Lab Operations with Automation - Episode 2: Pharma workflows
<ul>
<li>Tuesday, July 09, 2024, 11:00 AM CEST</li>
</ul>
<blockquote>
Presenter: Jasper Eaton (Senior Product Marketing Manager, Waters Corporation)
</blockquote>
<blockquote>
Jasper has a Bachelor’s degree in General Biology and obtained a Masters Degree in Molecular and Cellular Biology from the University of Grenoble-Alpes. He was previously the EU Sales Manager at Andrew Alliance since 2017, and is now a Senior Product Marketing Manager at Waters Corporation. His experience has made him well versed in the challenges faced by customers looking to automate their lab workflows.
</blockquote>
<blockquote>
Presenter: Xavier Rodriguez (Principal Applications Specialist, Chemistry, Europe, Waters Corporation)
</blockquote>
<blockquote>
Xavier is part of the European Market Development Team. He works as an Application Specialist with focus on sample prep and has more than 20 years of experience in solving sample prep challenges.
</blockquote>

Waters Corporation: Transform Your Daily Lab Operations with Automation - Episode 3: Food and Environmental Workflows

Transform Your Daily Lab Operations with Automation - Episode 3: Food and Environmental Workflows

We’ll show how Andrew+ and OneLab use automation to streamline everything from drug discovery to quality control.

Automation with Andrew+: Food and Environmental Workflows

Delivering connected science for your lab evolution
In the fast-paced world of laboratory operations, staying ahead of regulatory changes, increasing demands, and fierce competition is essential. However, outdated instrumentation and software can often hinder your progress.
Our newly launched software is meticulously crafted to elevate laboratory efficiency and ensure reproducibility, all while minimising manual errors. One of the core tenets of our software is its user-friendly interface, designed with simplicity in mind. Here’s your opportunity to get firsthand experience!
<h3>AGENDA</h3>
<h5>09:00 Welcome + Coffee + Networking</h5>
<h5>09:30 Introduction to waters_connect: Delivering connected science for your lab evolution</h5>
<h5>09:45 Streamlining System Setup and Data Acquisition: Maximizing efficiency and accuracy</h5>
<h5>10:30 Coffee and networking opportunities</h5>
<h5>11:00 Compound optimization with just a few clicks - Hands-on workshop</h5>
<h5>11:45 Mastering MS Quan: Demonstration of next generation of data processing</h5>
<h5>12:30 Lunch</h5>
<h5>13:30 Mastering MS Quan: Unleash your analytical potential- hands-on workshop</h5>
<h5>15:30 General discussion, coffee and wrap-up</h5>

Waters Corporation: waters_connect for Quantitation workshop

waters_connect for Quantitation workshop

Here’s your opportunity to get firsthand experience.

Join CNPN and US HUPO&#39;s ECR as they explore innovative proteomic techniques aimed at studying PTMs, including proteolysis, and their profound impact on biological function.
<blockquote>
Presenter: Chris Overall
</blockquote>
<blockquote>
Professor Chris Overall is a Distinguished University Scholar of the University of British Columbia, a fellow of the Royal Society of Canada, a Canada Research Chair Laureate in Protease Proteomics and Systems Biology, a Yonsei Distinguished Scholar of Yonsei University, Korea, and a Senior Fellow of the Freiburg Institute of Advanced Studies, AlbertLudwigs Universität Freiburg, Germany, where he is an Honorary Professor. His 310 papersare influential, with an h-index of 107. He is best known for his development of terminomic methodology for the identification of protein N and C-termini for the identification of mature and neo-protein substrate termini in vivo. He Chairs the HUPO Chromosome-centric Human Proteome Project (C-HPP), sits on the 1st Council of the pi-Hub Global Proteomics Project, and is the recipient of numerous awards, e.g., CNPN Tony Pawson Award, the Proteomass Scientific Society Award; 2018 HUPO Discovery Award in Proteomics Sciences; and 2022 Helmut Holzer Award.
</blockquote>
<blockquote>
Presenter: Amy Weeks
</blockquote>
<blockquote>
Amy Weeks is an Assistant Professor of Biochemistry at the University of Wisconsin-Madison. She received her S.B. in Chemistry from the Massachusetts Institute of Technology and earned her Ph.D. in Chemistry at the University of California, Berkeley under the mentorship of Prof. Michelle Chang. She completed postdoctoral studies in the laboratory of Prof. James Wells at the University of California, San Francisco. Her research group engineers enzymatic tools for mapping biological signals across space and time in living cells. Using these tools, the lab seeks to provide an integrated view of cellular signaling to advance biological discovery and development of therapeutics for human disease.
</blockquote>

US HUPO: Chemical Biology and Enzymology in Proteomics

Chemical Biology and Enzymology in Proteomics

Innovative proteomic techniques aimed at studying PTMs, including proteolysis, and their profound impact on biological function.

MALDI Top-Down Sequencing (MALDI-TDS) delivers N- and C-terminal sequence readout for intact proteins or protein subunits within minutes.
Leverage the novel neofleX™ MALDI-TDS workflow for verification of therapeutic antibodies, antigens and other protein expression products regarding sequence, terminal status and modifications and, thereby, enable instant decision making in strain development and production in biopharma or other branches of industry.
During this webinar, you will learn:
<ul>
<li>Overview of neofleX technology and its benefits to life sciences applications
</li>
<li>neofleX top-down workflow: Protein sequence verification with shortest time-to-result
</li>
<li>OmniScape™ software: From data to sequencing results with just a few mouse clicks
</li>
</ul>
Who should attend:
<ul>
<li>Characterization team leaders in biopharma companies and CROs
</li>
<li>Mass spectrometry core lab managers
</li>
<li>Researchers who are interested in fast protein characterization methods
</li>
<li>Anyone who needs to deliver instant sequence verification for protein expression products
</li>
<li>Anyone who would like to learn about the latest MALDI-TOF/TOF technology
</li>
</ul>
<blockquote>
Presenter: Jan Hendrik Kobarg, Ph.D. (Product Manager, MALDI-TOF, Bruker Daltonics, Bremen, Germany)
</blockquote>
<blockquote>
Jan Kobarg, Ph.D., is the product manager for the MALDI-TOF instrument portfolio at Bruker. The latest addition to the portfolio is the neofleX™ MALDI-TOF Benchtop instrument.
</blockquote>
<blockquote>
Presenter: Arndt Asperger, Ph.D. (Senior Applications Scientist, Bruker Daltonics, Bremen, Germany)
</blockquote>
<blockquote>
Arndt is analytical chemist by training and got his Ph.D. from Leipzig University. He joined Bruker in 2002 and has been working in various application related positions with a focus on pharma/biopharma.
</blockquote>

Bruker: LabCast: Simple and fast top-down protein characterization using neofleX benchtop MALDI-TOF/TOF

LabCast: Simple and fast top-down protein characterization using neofleX benchtop MALDI-TOF/TOF

Overview of neofleX technology and its benefits to life sciences applications.

LabCast: Simple and fast top-down protein characterization

The sample throughput of high-sensitivity liquid chromatography-mass spectrometry (LC-MS) based proteomics analysis is restricted by the pressure limitations of LC and column hardware, with some methods wasting as much as 50% of the method cycle time outside of MS acquisition.
Traditional routes for boosting throughput include shorter columns and gradients, higher flow rates, and using trap-and-elute workflows – all of which introduce trade-offs in sensitivity and proteome depth.
The Thermo Scientific™ Vanquish™ Neo tandem direct injection workflow leverages hardware innovations and software intelligence to eliminate method overhead while maintaining data quality across nano, capillary, and micro-flow LC-MS.
In this webinar experts from Evotec and Bayer will showcase how they implemented the tandem direct injection workflow for their proteomics work. Dr. Nagarjuna Nagaraj will present on how Evotec is using tandem direct injection with nano-LC columns packed in-house to boost sample throughput of their chemoproteomics screening pipeline, while Dr. Alexander Boychenko from Bayer will discuss how his lab is using a micro-flow tandem direct injection approach to analyze plasma samples for translational proteomics.
Learning Objectives
<ul>
<li>See how minimizing LC-MS method overhead can accelerate sample throughput while maintaining proteome depth
</li>
<li>Discover how labs are using tandem direct injection for chemoproteomics and translational proteomics applications
</li>
<li>Learn how to implement tandem direct injection in your proteomics workflow
</li>
</ul>
<blockquote>
Presenter: Dr. Nagarjuna Nagaraj (Group Leader High Sensitivity Proteomics, Evotec)
</blockquote>
<blockquote>
Dr. Nagarjuna Nagaraj is a proteomics group leader at Evotec focusing on high sensitivity and high throughput proteomics applications with more than 18 years of experience in proteomics and mass spectrometry. Nagarjuna obtained his PhD from the Matthias Mann lab focusing on sample preparation and MS data acquisition strategies for clinical applications. After a postdoc he directed the mass spectrometry core facility at the Max-Planck-Institute of Biochemistry working on a wide range of protein and peptide mass spectrometry projects such as bottom-up proteomics, structural mass spectrometry including HDX, native and crosslinking MS, intact protein and small molecule analysis.
</blockquote>
<blockquote>
Presenter: Dr. Alexander Boychenko (Head of R&amp;D Laboratory Precision Medicine Markers, Bayer)
</blockquote>
<blockquote>
Alexander Boychenko is leading Omics Research within the Translational Sciences team of the Pharmaceuticals division at Bayer Group. He is focused on implementing innovative analytical technologies and developing novel methodologies for proteomics, metabolomics, and ligand-binding assays (LBA) to comprehensively characterize human and animal model phenotypes, enabling disease understanding and novel biomarker discovery. He holds a Ph.D. in Analytical Chemistry from Kharkiv National University, Ukraine. During his post-doctoral work at the University of Groningen, The Netherlands, he combined LC-MS and immunoassays to discover and validate protein biomarkers in biofluids for cancer screening. Before joining Research and Early Development at Bayer AG, he developed and introduced new liquid chromatography-mass spectrometry products at Thermo Fisher Scientific. Alexander is a subject matter expert in LC-MS, biological data interpretation, and precision medicine. He utilizes his passion for applying technical expertise to develop new medicines.
</blockquote>
<blockquote>
Presenter: Dr. Alec Valenta (Product Marketing Manager, Thermo Fisher Scientific)
</blockquote>
<blockquote>
Alec is the product marketing manager for the Vanquish Neo UHPLC system and low-flow LC columns. Prior to joining Thermo Fisher Scientific he earned his PhD in analytical chemistry from the University of Michigan where he helped advance microdialysis sampling of neurochemicals and developed LC-MS methods to quantify small molecule neurotransmitters, neuropeptides, and metabolites in a variety of complex biological samples.
</blockquote>

Thermo Scientific: A Tandem LC Workflow for Maximizing Mass Spectrometer Utilization in Proteomics

A Tandem LC Workflow for Maximizing Mass Spectrometer Utilization in Proteomics

How experts from Evotec and Bayer implemented the tandem direct injection workflow for their proteomics work.

A Tandem LC Workflow for Maximizing Mass Spectrometer

The allowable adjustments to compendial methods published in USP General Chapter 621 and Ph. Eur. 2.2.46 provide scope for analysts to migrate methods to smaller column dimensions, providing advantages in terms of time and cost savings.This webinar will provide insight into the considerations necessary when applying allowable adjustments to gradient monographs.<h4>Key Learning Points:</h4><ul><li>Learn about Allowable adjustments possible when working with gradient monograph methods</li><li>Understand system considerations in terms of dwell volume</li><li>Dig into calculations to perform in order to scale gradient conditions correctly</li></ul><h4>Who Should Attend:</h4><ul><li>Any analysts working with pharmacopeia methods or chromatographers who work with gradient methods&nbsp;</li></ul><blockquote>Presenter: James Turner (Global Market Manager, Phenomenex)With more than 25 years of experience at Phenomenex, James has been responsible for providing specialist technical support to customers across Europe with method development assistance, troubleshooting advice and chromatographic solutions to various customer problems. James has also been involved with the technical training of many Phenomenex technical consultants, across the multiple techniques we serve.</blockquote>

Phenomenex: Working with Allowed Adjustments Pharmacopeia HPLC Methods – Gradient Considerations

Working with Allowed Adjustments Pharmacopeia HPLC Methods – Gradient Considerations

Insight into the considerations necessary when applying allowable adjustments to gradient monographs.

Working with Allowed Adjustments Pharmacopeia HPLC

Understanding disease at a biological level requires deep, precise analysis. Multi-omics assays provide this depth, offering critical insights into human health and disease progression. However, these advanced methods come with challenges—especially when it comes to standardization and reproducibility.<h4>Join us for an informative webinar and panel discussion where we will:</h4><ul><li>Explore Quantitative Metabolomics: Discover how this powerful approach distinguishes health from disease and unlocks new insights into biological mechanisms.&nbsp;</li><li>Learn About Automated Sample Preparation: Get up to speed on the latest advancements in automated workflows, including the use of kit-based LC-MS/MS for reliable metabolomics profiling.Enhance Your Research Efficiency: Understand how integrating advanced technologies can streamline the verification and monitoring of potential biomarkers, leading to more cohesive analytical workflows.</li></ul><h4>Featured Presentations</h4><ul><li>Hear from experts at the University of Minnesota and University of Surrey as they showcase real-world applications and validations of these workflows. You'll gain exclusive insights from leaders in the field who are at the forefront of metabolomics research.</li></ul><h4>Key Learning Points</h4><ul><li>Unlock the Power of Quantitative Metabolomics: Learn how this approach helps differentiate health from disease and provides crucial insights into biological processes.</li><li>Streamline Your Research: Discover how comprehensive analytical workflows can speed up the verification and monitoring of lipid and small molecule biomarkers.</li><li>Dive into Advanced Automation: Explore cutting-edge sample preparation with the Waters™ Andrew+ automated liquid handler and the biocrates MxP® Quant 500 kit, transforming targeted metabolomics studies.</li><li>Master LC-MS/MS Workflows: Gain insights into the expanded biocrates MxP® Quant 500 XL, optimized for use with the Waters Xevo™ TQ Absolute MS, for robust lipidomics and metabolomics data.</li><li>Engage with Leading Experts: Take advantage of the opportunity to interact with experts from the University of Minnesota, University of Surrey, Waters Corporation, and Biocrates.</li></ul><blockquote>Presenter: Dr Holly-May Lewis (Senior Laboratory Technician, University of Surrey, UK)Dr. Holly-May Lewis is a Senior Laboratory Technician and specialist in Liquid Chromatography Mass Spectrometry (UPLC-MS/MS) at the University of Surrey's Chronobiology Section. With a PhD in Chemistry from the University of Surrey, she brings deep expertise in analytical chemistry to her current work, where she focuses on cutting-edge UPLC-MS/MS metabolomics of human samples.Presenter:&nbsp;Professor Debra Skene PhD (Professor of Neuroendocrinology, University of Surrey, UK)Debra J. Skene, PhD, FMedSci is a distinguished Professor of Neuroendocrinology in the Chronobiology Section at the University of Surrey, UK. With over 30 years of research experience and more than 200 peer-reviewed publications, her work focuses on the human circadian timing system and related sleep/wake disorders, particularly in blind individuals, shift workers, and older adults. Currently, her research explores the links between circadian clocks, sleep, and metabolism in both health and disease, utilizing advanced metabolomics techniquesPresenter:&nbsp;Dr Zachary J Mayer (Research Scientist at the Center for Metabolomics and Proteomics (CMSP), University of Minnesota)Dr Zachary Mayer is a Research Scientist at the Center for Metabolomics and Proteomics (CMSP) at the University of Minnesota, specializing in high-throughput targeted metabolomics by Liquid Chromatography Mass Spectrometry (LC-MS), sample preparation, and laboratory automation.</blockquote>

Waters Corporation: LC-MS/MS Workflows for Kit Based Quantitative Metabolic Profiling

LC-MS/MS Workflows for Kit Based Quantitative Metabolic Profiling

Multi-omics assays provide this depth, offering critical insights into human health and disease progression.

LC-MS/MS Workflows for Kit Based Quantitative Metabolic

Nitrosamine Drug Substance-Related Impurities (NDSRI's) are a class of impurities that can form in drug substances and products. These impurities are of significant concern due to their potential carcinogenicity. Regulatory bodies, including the FDA, have established guidelines and acceptable intake limits to ensure the safety and efficacy of medications.NDSRI webinar series is a comprehensive three-part webinar series designed to provide valuable insights into the evolving landscape of analytical methods and regulatory requirements. This series will cover critical topics that are essential for professionals in the field.Key learnings:<ul><li>Understanding Nitrosamine / NDSRI and their impact on drug safety.</li><li>Latest regulatory guidelines and requirements.</li><li>Navigating Nitrosamines with Agilent 21 CFR compliant mass Hunter Software.</li><li>A focus on components in chromatographic challenges, with examples of NDSRI methods.</li><li>Case studies and real-world applications.</li><li>Column and consumable selection and how it influences the analysis.</li><li>Best practice for method optimization, development, and automation.</li><li>and more</li></ul><blockquote>Presenter: Dr. Kuldeep Sharma (Sales Development Manager - Pharma, Agilent Technologies)Kuldeep Sharma has over 19 years of experience in area/s of Bioanalytical research, Drug metabolism &amp; pharmacokinetics and Pharma regulatory compliance. He has accomplished PhD in Biotechnology. His professional journey covers over 12 years in Analytical research (associated with R&amp;D’s of Zydus Cadila, Lambda, Pliva and Jubilant Biosys) and last 7 years in analytical instruments sales, marketing &amp; business development. With over 21 research articles published in international Journals, He presents convention of continues learning.Presenter:&nbsp;Dr. Prasanth Joseph (Application Engineer - LC/MS, Agilent Technologies)Prasanth is an experienced analytical instrumentation professional with a specialization in small molecule applications. Joining Agilent in 2015 as an Application Engineer for LC-MS/MS, he has 19 years of expertise in the field. Prasanth holds a Ph.D. in Environmental Science from Bharathiar University, India, and a master's degree in Business Administration from the University of Buckingham, UK. His extensive knowledge includes developing analytical methods for quantifying genotoxic impurities, analyzing extractables and leachables in pharma and food packaging, conducting bioavailability and bioequivalence studies, and more. Prasanth's proficiency extends to the analysis of phytochemicals, food residue screening, and environmental sample contaminants.Presenter:&nbsp;Mr. Ankush Sharma (Regional Marketing Program Manager- APAC (Pharma &amp; Biopharma), Agilent Technologies)Ankush Sharma is a seasoned professional with over 12 years of extensive experience in sales and marketing across the pharmaceutical and biopharmaceutical sectors. His professional journey commenced with a strong educational foundation, earning a Master's degree in Biotechnology. Building upon this knowledge, he furthered his academic pursuits by obtaining a Master's in Business Administration with a specialization in Sales and Marketing, demonstrating his commitment to blending scientific understanding with strategic business acumen. For the past five years, he has been an integral part of Agilent, serving as the Regional Marketing Program Manager for the India and now Asia-Pacific (APAC) region for Pharma and Biopharma Markets.</blockquote>

Agilent: Nitrosamines & NDSRI's: Be sure with Agilent workflows

Nitrosamines & NDSRI's: Evolving Regulatory Landscape in Nitrosamines and NDSRI’s analysis.

NDSRI webinar series is designed to provide valuable insights into the evolving landscape of analytical methods and regulatory requirements.

Nitrosamines & NDSRI's: Be sure with Agilent workflows

<h4>Overview</h4>We invite you to our 2nd Annual Virtual Biosymposium. This year, we will explore novel analytical characterization and quantitation of emerging modalities, such as DNA and mRNA, along with key method development considerations with global thought leaders.We look forward to seeing you! Key Event Objectives:<ul><li>Learn about novel approaches to characterizing established and modern biotherapeutic modalities</li><li>Understand key considerations when developing characterizing and quantitating methods for biomolecules</li><li>Take a deep dive into the values of fit-for-purpose methods to make critical drug decisions</li></ul>AGENDA7:30am AM (PT) - Welcoming Introductions<ul><li>Tran N. Pham, Global Biopharma Market Development Manager at Phenomenex</li></ul>7:35 AM (PT) - "Solutions &amp; Characterization Strategies for IVT mRNA Therapy Development"<ul><li>Charles Bai, Lead Application Scientist, VectorBuilder, Chicago, USA</li></ul>8:05 AM (PT) - &nbsp;"Utilizing Size Exclusion Chromatography for the Quality Control Analysis of Gene Therapeutics”<ul><li>Rebecca Hirschberger, QC Manager Bioanalytical Implementation, and Dr. Christopher Gawlig, QC Manager Research and development, Biospring, Germany</li></ul>8:35 AM (PT) "Impurity Profiling Optimization of GalNAc-conjugated Oligonucleotides by LC-MS-UV"<ul><li>Roxana Eggleston-Rangel, Senior Applications Scientist, Phenomenex, California, USA</li></ul>9:05 AM (PT) – Round Table Q&amp;A<ul><li>Tran N. Pham, Global Biopharma Market Development Manager at Phenomenex</li></ul>9:25 AM (PT) – Closing Remarks<blockquote>Presenter: Charles Bai (Lead Application Scientist)Charles has received his PhD in Microbiology at Purdue University. As a Lead Application Scientist at VectorBuilder, his main responsibilities are to provide technical consultation for clients regarding gene delivery using viral and non-viral vectors. Regarding the application of in vitro transcribed (IVT) RNA, Charles has been helping researchers with the design, production and encapsulation of IVT mRNA, circRNA or saRNA for therapy and vaccine development.Presenter: Rebecca Hirschberger (Quality Control Bioanalytical Method Development)Rebecca has been in the chromatography industry for over 2 years and has practical experience in the quality control of gene therapeutics. She has earnt a Masters in pharmaceutical science from Ludwig-Maximilians University, Munich, focused on instrumental analytics. Since Dezember 2022 she is a licensed Pharmacist in Germany. Rebecca Hirschberger joined BioSpring in August of 2021 and she serves as QC Manager Bioanalytical Implementation. Her area of responsibility includes: Various analyses of oligonucleotides, including (tandem) mass spectrometry via qToF, biochemical techniques, i.e. ELISA, enzymatic transformation of oligonucleotides for analytical and quality control purposes and the Separation of oligonucleotides by chromatographic methods.Presenter: Roxana Eggleston-Rangel (Senior Applications Scientist, Phenomenex)Roxana joined Phenomenex in 2018 as an Applications Scientist and is currently working with the applications team to produce analytical solutions for scientist in the biopharma industry. Roxana’s current work focuses on characterization of mRNA, sgRNA and siRNA. Prior to Phenomenex, Roxana worked for Caltech and the University of Southern California developing LM-CS workflows for the proteomics community. Roxana Eggleston-Rangel received her bachelor’s and master’s degree in Chemistry and Biochemistry from California State University, Los Angeles.</blockquote>

Phenomenex: 2nd Annual Virtual Biosymposium

2nd Annual Virtual Biosymposium

Explore novel analytical characterization and quantitation of emerging modalities, such as DNA and mRNA